3.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Omeros Corporation Borsa (OMER) Ultime notizie
Omeros (OMER) Stock Rating and Price Target Maintained by D. Boral Capital | OMER Stock News - GuruFocus
Omeros Secures $22 Mln In Registered Direct Offering With Polar Asset Management - Nasdaq
Is Omeros Corporation a good long term investmentHigh-yield portfolio picks - PrintWeekIndia
Omeros stock rises after $22 million registered direct offering - Investing.com India
Omeros (OMER) Conducts $22M Stock Sale Through Direct Offering | - GuruFocus
Omeros to raise $22 million in registered direct offering By Investing.com - Investing.com South Africa
Omeros to raise $22 million in registered direct offering - Investing.com India
Omeros Enters Securities Purchase Agreement with Polar - TipRanks
Omeros Corporation Announces Pricing of $22 Million Registered D - GuruFocus
Form 424B5 OMEROS CORP - StreetInsider
Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering - The Joplin Globe
What analysts say about Omeros Corporation stockLightning-fast growth - Autocar Professional
Omeros Corporation Stock Analysis and ForecastPhenomenal trading returns - jammulinksnews.com
What drives Omeros Corporation stock priceStrongest growth potential - jammulinksnews.com
Why Omeros Corporation stock attracts strong analyst attentionAnalyst Grade Signals - Newser
How Omeros Corporation stock performs during market volatilityStrategic High Profit Opportunities - beatles.ru
what makes omeros corporation stock price move sharplyFree Access to Community - Newser
FY2027 Earnings Forecast for Omeros Issued By HC Wainwright - Defense World
What makes Omeros Corporation stock price move sharplyWatchlist Winner Update - Newser
Omeros Corporation (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN
Wealth Enhancement Advisory Services LLC Takes $579,000 Position in Omeros Corporation (NASDAQ:OMER) - Defense World
Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN
Both retail investors who control a good portion of Omeros Corporation (NASDAQ:OMER) along with institutions must be dismayed after last week's 12% decrease - simplywall.st
Omeros shareholders elect directors and approve executive pay at annual meeting - Investing.com
Omeros stock maintains Buy rating at H.C. Wainwright on EU submission - Investing.com
Omeros (NASDAQ:OMER) Downgraded by Wall Street Zen to “Sell” - Defense World
Omeros' Narsoplimab: A Lifeline for TA-TMA Patients and a Regulatory Crossroads - AInvest
Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA | OMER Stock News - GuruFocus
Omeros (OMER) Eyes European Approval for Key Drug Narsoplimab | OMER Stock News - GuruFocus
Omeros Announces Webcast Details for Annual Meeting of Shareholders - FinancialContent
Ratios Revealed: Decoding Omeros Corporation (OMER)’s Financial Health - DWinneX
Omeros Co. (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
What is HC Wainwright’s Forecast for Omeros FY2025 Earnings? - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):